Dianthus Therapeutics (DNTH) Capital Expenditures (QoQ) (2017 - 2025)
Dianthus Therapeutics (DNTH) Capital Expenditures (QoQ) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Dianthus Therapeutics | 3.92 Bn | 3.51 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -89.13% |
| Jun 30, 2025 | 91.67% |
| Mar 31, 2025 | -22.58% |
| Dec 31, 2024 | 24.00% |
| Sep 30, 2024 | 47.06% |
| Jun 30, 2024 | -46.88% |
| Mar 31, 2024 | 220.00% |
| Dec 31, 2023 | -84.62% |
| Sep 30, 2023 | 209.52% |
| Jun 30, 2023 | 50.00% |
| Mar 31, 2023 | -51.72% |
| Dec 31, 2022 | 163.04% |
| Sep 30, 2022 | -135.66% |
| Jun 30, 2022 | 377.78% |
| Mar 31, 2022 | 80.00% |
| Dec 31, 2021 | -98.67% |
| Sep 30, 2021 | 918.92% |
| Jun 30, 2021 | 1,485.71% |
| Mar 31, 2021 | -96.71% |
| Dec 31, 2020 | 965.00% |